{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:20:35Z","timestamp":1787314835688,"version":"build-2736575974"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Serotonergic dysfunction, including reduced central serotonin levels, is associated with different psychiatric syndromes, including depression. As a serotonin precursor, 5-hydroxytryptophan has long been used as a nonpharmacological treatment for depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis was conducted to determine the antidepressant effects of 5-hydroxytryptophan in depressed patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>MEDLINE (via PubMed) and Google Scholar were searched from inception to May 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction<\/jats:title>\n                    <jats:p>Thirteen investigations were included in the systematic review (using PRISMA guidelines), and 7 in the full meta-analysis (pre-registered on PROSPERO: CRD42018104415).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data analysis<\/jats:title>\n                    <jats:p>Analyses revealed a depression remission rate of 0.65 (95% confidence interval [CI], 0.55\u20130.78; remission rate [k]\u2009=\u200913), and this was confirmed by the questionnaire results, which revealed a large Hedges\u2019 g (1.11; 95%CI, 0.53\u20131.69). Methodological variability (in treatment duration, type of depression studied, experimental design, 5-hydroxytryptophan dosage) contributes to heterogeneity in the results (I2\u2009=\u200976%, \u03c42\u2009=\u20090.379). In addition, the OHAT (Office of Health Assessment and Translation risk of bias rating) tool suggested that, on the whole, current studies are relatively weak (few include placebo groups).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Further trials should overcome these limitations by using placebo-controlled studies that include patients with well-defined depression diagnoses, along with strong characterization of psychological and physiological patient characteristics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/nutrit\/nuz039","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T15:18:13Z","timestamp":1557415093000},"page":"77-88","source":"Crossref","is-referenced-by-count":32,"title":["Effects of 5-hydroxytryptophan on distinct types of depression: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"78","author":[{"given":"Florian","family":"Javelle","sequence":"first","affiliation":[{"name":"Florian Javelle, Wilhelm Bloch, and Philipp Zimmer are with the Clinical Exercise-Neuro-Immunology Group, Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University, Cologne, Germany. Amit Lampit is with the Department of Psychiatry, The University of Melbourne, Melbourne, Australia. Amit Lampit is with the Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Lampit","sequence":"additional","affiliation":[{"name":"Florian Javelle, Wilhelm Bloch, and Philipp Zimmer are with the Clinical Exercise-Neuro-Immunology Group, Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University, Cologne, Germany. Amit Lampit is with the Department of Psychiatry, The University of Melbourne, Melbourne, Australia. Amit Lampit is with the Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Bloch","sequence":"additional","affiliation":[{"name":"Florian Javelle, Wilhelm Bloch, and Philipp Zimmer are with the Clinical Exercise-Neuro-Immunology Group, Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University, Cologne, Germany. Amit Lampit is with the Department of Psychiatry, The University of Melbourne, Melbourne, Australia. Amit Lampit is with the Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"H\u00e4ussermann","sequence":"additional","affiliation":[{"name":"Florian Javelle, Wilhelm Bloch, and Philipp Zimmer are with the Clinical Exercise-Neuro-Immunology Group, Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University, Cologne, Germany. Amit Lampit is with the Department of Psychiatry, The University of Melbourne, Melbourne, Australia. Amit Lampit is with the Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri L","family":"Johnson","sequence":"additional","affiliation":[{"name":"Florian Javelle, Wilhelm Bloch, and Philipp Zimmer are with the Clinical Exercise-Neuro-Immunology Group, Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University, Cologne, Germany. Amit Lampit is with the Department of Psychiatry, The University of Melbourne, Melbourne, Australia. Amit Lampit is with the Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Florian Javelle, Wilhelm Bloch, and Philipp Zimmer are with the Clinical Exercise-Neuro-Immunology Group, Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University, Cologne, Germany. Amit Lampit is with the Department of Psychiatry, The University of Melbourne, Melbourne, Australia. Amit Lampit is with the Department"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"2019121710572328800_nuz039-B1","year":"2018"},{"key":"2019121710572328800_nuz039-B2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/acps.12395","article-title":"The differential influence of life stress on individual symptoms of depression","volume":"131","author":"Fried","year":"2015","journal-title":"Acta Psychiatr Scand."},{"key":"2019121710572328800_nuz039-B3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0269881115609072","article-title":"The serotonergic system in the neurobiology of depression: relevance for novel antidepressants","volume":"30","author":"K\u00f6hler","year":"2016","journal-title":"J Psychopharmacol."},{"key":"2019121710572328800_nuz039-B4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.mp.4001015","article-title":"Delayed pharmacological effects of antidepressants","volume":"7","author":"Frazer","year":"2002","journal-title":"Mol Psychiatry"},{"key":"2019121710572328800_nuz039-B5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13041-017-0306-y","article-title":"The role of 5-HT receptors in depression","volume":"10","author":"Yohn","year":"2017","journal-title":"Mol Brain."},{"key":"2019121710572328800_nuz039-B6","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/npp.2009.75","article-title":"Antidepressants increase neural progenitor cells in the human hippocampus","volume":"34","author":"Boldrini","year":"2009","journal-title":"Neuropsychopharmacology."},{"key":"2019121710572328800_nuz039-B7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/S1092852915000425","article-title":"Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function","volume":"21","author":"Dale","year":"2016","journal-title":"CNS Spectr."},{"key":"2019121710572328800_nuz039-B8","doi-asserted-by":"crossref","first-page":"20120536.","DOI":"10.1098\/rstb.2012.0536","article-title":"Serotonin and beyond: therapeutics for major depression","volume":"368","author":"Blier","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2019121710572328800_nuz039-B9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/NDT.S33259","article-title":"5-HTP efficacy and contraindications","volume":"8","author":"Hinz","year":"2012","journal-title":"Neuropsychiatr Dis Treat."},{"key":"2019121710572328800_nuz039-B10","first-page":"64","article-title":"Use of neurotransmitter precursors for treatment of depression","volume":"5","author":"Meyers","year":"2000","journal-title":"Altern Med Rev"},{"key":"2019121710572328800_nuz039-B11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuint.2012.12.014","article-title":"Effect of diet on serotonergic neurotransmission in depression","volume":"62","author":"Shabbir","year":"2013","journal-title":"Neurochem Int"},{"key":"2019121710572328800_nuz039-B12","doi-asserted-by":"crossref","first-page":"20110375.","DOI":"10.1098\/rstb.2011.0375","article-title":"The effect of raising and lowering tryptophan levels on human mood and social behaviour","volume":"368","author":"Young","year":"2013","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"2019121710572328800_nuz039-B13","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2174\/1871527313666141130203245","article-title":"Effects of physical exercise on depressive symptoms and biomarkers in depression","volume":"13","author":"Archer","year":"2014","journal-title":"CNS Neurol Disord Drug Targets."},{"key":"2019121710572328800_nuz039-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2011.10.012","article-title":"From depressive symptoms to depression in people with epilepsy: contribution of physical exercise to improve this picture","volume":"99","author":"Arida","year":"2012","journal-title":"Epilepsy Res"},{"key":"2019121710572328800_nuz039-B15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1467-9450.2007.00566.x","article-title":"Impulsivity as a predictor of newly diagnosed depression","volume":"48","author":"Gran\u00f6","year":"2007","journal-title":"Scand J Psychol."},{"key":"2019121710572328800_nuz039-B16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00422612","article-title":"A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant","volume":"25","author":"van Praag","year":"1972","journal-title":"Psychopharmacologia"},{"key":"2019121710572328800_nuz039-B17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pbb.2007.12.021","article-title":"Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry","volume":"90","author":"Dalley","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"2019121710572328800_nuz039-B18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.2044-8341.2012.02078.x","article-title":"Impulsivity and risk for mania: towards greater specificity","volume":"86","author":"Johnson","year":"2013","journal-title":"Psychol Psychother"},{"key":"2019121710572328800_nuz039-B19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0893-133X(99)00086-X","article-title":"Effects on mood of acute phenylalanine\/tyrosine depletion in healthy women","volume":"22","author":"Leyton","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"2019121710572328800_nuz039-B20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archpsyc.1990.01810170011002","article-title":"Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan","volume":"47","author":"Delgado","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"2019121710572328800_nuz039-B21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/sj.npp.1301212","article-title":"Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression","volume":"32","author":"van der Veen","year":"2007","journal-title":"Neuropsychopharmacology."},{"key":"2019121710572328800_nuz039-B22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.euroneuro.2009.10.003","article-title":"CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls","volume":"20","author":"Moreno","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"2019121710572328800_nuz039-B23","first-page":"253","article-title":"Social behaviour and mood in everyday life: the effects of tryptophan in quarrelsome individuals","volume":"31","author":"Aan Het Rot","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"2019121710572328800_nuz039-B24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/DHPS.S24798","article-title":"Monoamine depletion by reuptake inhibitors","volume":"3","author":"Hinz","year":"2011","journal-title":"Drug Healthc Patient Saf."},{"key":"2019121710572328800_nuz039-B25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.apnu.2014.11.008","article-title":"The effects of dietary tryptophan on affective disorders","volume":"29","author":"Lindseth","year":"2015","journal-title":"Arch Psychiatr Nurs"},{"key":"2019121710572328800_nuz039-B26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1017\/S0007114510004150","article-title":"Effect of hydrolysed egg protein on brain tryptophan availability","volume":"105","author":"Mitchell","year":"2011","journal-title":"Br J Nutr."},{"key":"2019121710572328800_nuz039-B27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s11357-012-9419-5","article-title":"Tryptophan-enriched cereal intake improves nocturnal sleep, melatonin, serotonin, and total antioxidant capacity levels and mood in elderly humans","volume":"35","author":"Bravo","year":"2013","journal-title":"Age (Omaha)"},{"key":"2019121710572328800_nuz039-B28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.12740\/PP\/29367","article-title":"Natural products of relevance in the prevention and supportive treatment of depression","volume":"49","author":"Muszy\u0144ska","year":"2015","journal-title":"Psychiatr Pol."},{"key":"2019121710572328800_nuz039-B29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0893-133X(01)00219-6","article-title":"The effect of tryptophan on social interaction in everyday life: a placebo-controlled study","volume":"25","author":"Moskowitz","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"2019121710572328800_nuz039-B30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","article-title":"Kynurenine pathway in depression: a systematic review and meta-analysis","volume":"90","author":"Ogyu","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"2019121710572328800_nuz039-B31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2014.07.051","article-title":"Skeletal muscle PGC-1\u03b11 modulates kynurenine metabolism and mediates resilience to stress-induced depression","volume":"159","author":"Agudelo","year":"2014","journal-title":"Cell"},{"key":"2019121710572328800_nuz039-B32","doi-asserted-by":"crossref","first-page":"e1000100.","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"2019121710572328800_nuz039-B33","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-21416-0","volume-title":"Meta-Analysis with R","author":"Schwarzer","year":"2015"},{"key":"2019121710572328800_nuz039-B34","volume-title":"Statistical Methods for Meta-Analysis","author":"Hedges","year":"1985"},{"key":"2019121710572328800_nuz039-B35","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1977"},{"key":"2019121710572328800_nuz039-B36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2019121710572328800_nuz039-B37","first-page":"646","article-title":"The indoleamine hypothesis of depression: an overview and pilot study","volume":"38","author":"Zarcone","year":"1977","journal-title":"Dis Nerv Syst."},{"key":"2019121710572328800_nuz039-B38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajp.2012.05.011","article-title":"Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode","volume":"6","author":"Jangid","year":"2013","journal-title":"Asian J Psychiatr"},{"key":"2019121710572328800_nuz039-B39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000284698","article-title":"A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine","volume":"24","author":"P\u00f6ldinger","year":"1991","journal-title":"Psychopathology"},{"key":"2019121710572328800_nuz039-B40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000117687","article-title":"L-5-HTP treatment and serum 5-HT level after L-5-HTP loading on depressed patients","volume":"5","author":"Kaneko","year":"1979","journal-title":"Neuropsychobiology"},{"key":"2019121710572328800_nuz039-B41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1440-1819.1978.tb00143.x","article-title":"Clinical evaluation of 5-hydroxy-L-tryptophan as an antidepressant drug","volume":"32","author":"Nakajima","year":"1978","journal-title":"Psychiatry Clin Neurosci."},{"key":"2019121710572328800_nuz039-B42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1440-1819.1976.tb02669.x","article-title":"Measurement of 5-hydroxyindole compounds during L\u20105-HTP treatment in depressed patients","volume":"30","author":"Takahashi","year":"1976","journal-title":"Psychiatry Clin Neurosci."},{"key":"2019121710572328800_nuz039-B43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0022-3956(75)90025-4","article-title":"Effect of L-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients","volume":"12","author":"Takahashi","year":"1975","journal-title":"J Psychiatr Res"},{"key":"2019121710572328800_nuz039-B44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1440-1819.1974.tb02290.x","article-title":"Subtype of affective psychoses classified by response on amineprecursors and monoamine metabolism","volume":"28","author":"Fujiwara","year":"1974","journal-title":"Psychiatry Clin Neurosci."},{"key":"2019121710572328800_nuz039-B45","first-page":"1895","article-title":"Etude clinique du 5-hydroxytryptophane dans les \u00e9tats d\u00e9pressifs du troisi\u00e8me \u00e2ge","volume":"50","author":"Bartlet","year":"1974","journal-title":"Cah M\u00e9d Lyon"},{"key":"2019121710572328800_nuz039-B46","first-page":"399","article-title":"The effect of L-5-hydroxytryptophan alone and in combination with a decarboxylase inhibitor (Ro-4-4602) in depressive patients","volume":"11","author":"Matussek","year":"1974","journal-title":"Adv Biochem Psychopharmacol"},{"key":"2019121710572328800_nuz039-B47","first-page":"549","article-title":"Clinical studies of L-5-hydroxytryptophan in depression","author":"Brodie","year":"1973","journal-title":"Serotonin Behav"},{"key":"2019121710572328800_nuz039-B48","first-page":"1713","article-title":"[L-5-hydroxytryptophan(L-5-HTP) therapy in endogenous depression. 1]","volume":"114","author":"Sano","year":"1972","journal-title":"Munch Med Wochenschr."},{"key":"2019121710572328800_nuz039-B49","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the Hamilton Depression Rating Scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch Gen Psychiatry."},{"key":"2019121710572328800_nuz039-B50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/JCP.0000000000000263","article-title":"Duration of initial antidepressant treatment and subsequent relapse of major depression","volume":"35","author":"Baldessarini","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"2019121710572328800_nuz039-B51","year":"2013"},{"key":"2019121710572328800_nuz039-B52","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0025-6196(12)61354-8","article-title":"The Eosinophilia-Myalgia syndrome: lessons from Germany","volume":"69","author":"Mayeno","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"2019121710572328800_nuz039-B53","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pneurobio.2010.06.003","article-title":"Depression and the role of genes involved in dopamine metabolism and signalling","volume":"92","author":"Opmeer","year":"2010","journal-title":"Prog Neurobiol"},{"key":"2019121710572328800_nuz039-B54","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/0333102416638520","article-title":"Genetic epidemiology of migraine and depression","volume":"36","author":"Yang","year":"2016","journal-title":"Cephalalgia"},{"key":"2019121710572328800_nuz039-B55","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1037\/a0033997","article-title":"Serotonin transporter genotype (5-HTTLPR) and electrocortical responses indicating the sensitivity to negative emotional cues","volume":"13","author":"Papousek","year":"2013","journal-title":"Emotion"},{"key":"2019121710572328800_nuz039-B56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: disease and healthy States","volume":"2","author":"Chen","year":"2009","journal-title":"Int J Tryptophan Res"}],"container-title":["Nutrition Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/78\/1\/77\/31556369\/nuz039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/78\/1\/77\/31556369\/nuz039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T10:57:49Z","timestamp":1576580269000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article\/78\/1\/77\/5555860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,8,28]]},"published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/nutrit\/nuz039","relation":{},"ISSN":["0029-6643","1753-4887"],"issn-type":[{"value":"0029-6643","type":"print"},{"value":"1753-4887","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,8,28]]}}}